This study seeks to gain a comprehensive understanding of current ARDS management practices across European ICUs, with a particular focus on the use of LTV and PP therapy, which have been shown to improve outcomes in ARDS patients. The primary objectives focus on evaluating how LTV and PP are implemented across different institutions, while secondary objectives encompass a broader assessment of other ARDS treatment strategies. These include mechanical ventilation approaches, including PEEP titration, the use of NMBAs, and advanced extra-corporal therapies like ECMO and extracorporeal carbon dioxide removal (ECCO2R). Additionally, the study will explore diagnostic methods and decision-making processes that guide ARDS management in diverse clinical settings.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of ICUs utilising prone positioning for ARDS patients.
Timeframe: Survey period (December 2024 - March 2025)
PaO2/FiO2 threshold for starting prone positioning.
Timeframe: Survey period (December 2024 - March 2025)
Distribution of the extent of prone positioning used in participating ICUs.
Timeframe: Survey period (December 2024 - March 2025).
Mean duration per prone positioning cycles.
Timeframe: Survey period (December 2024 - March 2025)
Mean minimum number of prone position cycles.
Timeframe: Survey period (December 2024 - March 2025)
Commonly reported criteria for ending prone positioning therapy.
Timeframe: Survey period (December 2024 - March 2025)
Proportion of ICUs adhering to tidal volume restrictions
Timeframe: Survey period (December 2024 - March 2025)
Mean tidal volumes used for mild, moderate, and severe ARDS.
Timeframe: Survey period (December 2024 - March 2025)